髓系白血病中的共抑制联盟：TIM-3/半乳凝素-9复合物作为检查点阻断疗法的新靶点 - Suppr

Suppr

超能文献

A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy.

作者信息

Kursunel M Alper, Esendagli Gunes

机构信息

Hacettepe University Cancer Institute, Department of Basic Oncology, 06100 Ankara, Turkey.

出版信息

EBioMedicine. 2017 Sep;23:6-7. doi: 10.1016/j.ebiom.2017.08.002. Epub 2017 Aug 4.

DOI:10.1016/j.ebiom.2017.08.002

PMID:28801238

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5605328/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47fa/5605328/11f6e112284e/gr1.jpg

相似文献

A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy.髓系白血病中的共抑制联盟：TIM-3/半乳凝素-9复合物作为检查点阻断疗法的新靶点

EBioMedicine. 2017 Sep;23:6-7. doi: 10.1016/j.ebiom.2017.08.002. Epub 2017 Aug 4.

[A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].[TIM-3/半乳糖凝集素-9自分泌刺激环驱动人类髓系白血病干细胞自我更新及白血病进展]

Rinsho Ketsueki. 2016 Apr;57(4):412-6. doi: 10.11406/rinketsu.57.412.

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.Tim-3/galectin-9 信号通路介导 T 细胞功能障碍，并预测乙型肝炎病毒相关性肝细胞癌患者的预后不良。

Hepatology. 2012 Oct;56(4):1342-51. doi: 10.1002/hep.25777.

Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.人胃肠道间质瘤中T细胞免疫球蛋白和粘蛋白3/半乳糖凝集素9免疫检查点分子对自然杀伤细胞抑制作用的表达

Oncol Rep. 2015 Oct;34(4):2099-105. doi: 10.3892/or.2015.4149. Epub 2015 Jul 24.

The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy.T 细胞免疫球蛋白黏蛋白-3 及其配体半乳糖凝集素-9 在抗肿瘤免疫和癌症免疫治疗中的作用。

Sci China Life Sci. 2017 Oct;60(10):1058-1064. doi: 10.1007/s11427-017-9176-7. Epub 2017 Oct 11.

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.Tim-3/galectin-9 通路参与伴刀豆球蛋白 A 诱导的肝炎小鼠模型中肝调节性 T 细胞的稳态。

Mol Immunol. 2014 Mar;58(1):85-91. doi: 10.1016/j.molimm.2013.11.001. Epub 2013 Dec 10.

Molecular cloning, characterization and expression analysis of Tim-3 and Galectin-9 in the woodchuck model.土拨鼠模型中Tim-3和半乳糖凝集素-9的分子克隆、特性分析及表达分析

Mol Immunol. 2017 Mar;83:127-136. doi: 10.1016/j.molimm.2017.01.018. Epub 2017 Jan 30.

The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells.免疫受体Tim-3介导人髓系白血病细胞中PI3激酶/mTOR和HIF-1信号通路的激活。

Int J Biochem Cell Biol. 2015 Feb;59:11-20. doi: 10.1016/j.biocel.2014.11.017. Epub 2014 Dec 5.

Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.免疫受体Tim-3在健康和恶性人类髓系细胞中的差异表达及生化活性

Oncotarget. 2015 Oct 20;6(32):33823-33. doi: 10.18632/oncotarget.5257.

Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4 T cells contributes to viral persistence in chronic hepatitis C.Galectin-9/TIM-3 通路与滤泡辅助性 CD4 T 细胞的相互作用导致慢性丙型肝炎病毒持续感染。

Biomed Pharmacother. 2017 Oct;94:386-393. doi: 10.1016/j.biopha.2017.07.134. Epub 2017 Aug 1.

引用本文的文献

Galectin Plasmatic Levels Reveal a Cluster Associated with Disease Aggressiveness and Kidney Damage in Multiple Myeloma Patients.半乳糖凝集素血浆水平揭示了与多发性骨髓瘤患者疾病侵袭性和肾损伤相关的一个集群。

Int J Mol Sci. 2024 Dec 17;25(24):13499. doi: 10.3390/ijms252413499.

Targeting the innate immune system in pediatric and adult AML.靶向治疗小儿和成人 AML 的固有免疫系统。

Leukemia. 2024 Jun;38(6):1191-1201. doi: 10.1038/s41375-024-02217-7. Epub 2024 Mar 8.

Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience.阿扎胞苷和维奈克拉的临床疗效以及Tim-3和半乳糖凝集素-9对急性髓系白血病和高危骨髓增生异常综合征的预后影响：一项单中心真实世界经验。

Front Pharmacol. 2022 Dec 21;13:1052060. doi: 10.3389/fphar.2022.1052060. eCollection 2022.

Higher TOX Genes Expression Is Associated With Poor Overall Survival for Patients With Acute Myeloid Leukemia.较高的TOX基因表达与急性髓系白血病患者较差的总生存期相关。

Front Oncol. 2021 Oct 8;11:740642. doi: 10.3389/fonc.2021.740642. eCollection 2021.

Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.血浆半乳糖凝集素-9 作为抑制性抗逆转录病毒治疗期间慢性 HIV 感染者不良非艾滋病事件的预测因子。

AIDS. 2021 Dec 1;35(15):2489-2495. doi: 10.1097/QAD.0000000000003048.

The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.TIM3/Gal9 信号通路：癌症免疫治疗的一个新靶点。

Cancer Lett. 2021 Jul 10;510:67-78. doi: 10.1016/j.canlet.2021.04.011. Epub 2021 Apr 22.

Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance.人类急性髓细胞白血病细胞实施的抑制宿主免疫监视的生化机制。

Cell Mol Immunol. 2018 Nov;15(11):989-991. doi: 10.1038/s41423-018-0047-6. Epub 2018 Jun 5.

本文引用的文献

The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells.Tim-3-半乳糖凝集素 9 分泌途径参与人类急性髓系白血病细胞的免疫逃逸。

EBioMedicine. 2017 Aug;22:44-57. doi: 10.1016/j.ebiom.2017.07.018. Epub 2017 Jul 19.

Second- and third-generation drugs for immuno-oncology treatment-The more the better?免疫肿瘤治疗的第二代和第三代药物——越多越好？

Eur J Cancer. 2017 Mar;74:55-72. doi: 10.1016/j.ejca.2017.01.001. Epub 2017 Feb 10.

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation.异基因造血干细胞移植后复发的急性髓系白血病患者的程序性死亡受体 1 检查点阻断治疗。

Bone Marrow Transplant. 2017 Feb;52(2):317-320. doi: 10.1038/bmt.2016.274. Epub 2016 Nov 28.

Tumor-infiltrating Tim-3 T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.肿瘤浸润性Tim-3 T细胞除了在共表达PD-1时外，会大量增殖：细胞内相互作用的证据。

Oncoimmunology. 2016 Sep 22;5(10):e1200778. doi: 10.1080/2162402X.2016.1200778. eCollection 2016.

Functional exhaustion of CD4 T cells induced by co-stimulatory signals from myeloid leukaemia cells.髓系白血病细胞共刺激信号诱导的CD4 T细胞功能耗竭。

Immunology. 2016 Dec;149(4):460-471. doi: 10.1111/imm.12665. Epub 2016 Sep 29.

PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells.程序性死亡蛋白1（PD1）阻断增强体外扩增的自然杀伤细胞对骨髓瘤细胞的细胞毒性。

Oncotarget. 2016 Jul 26;7(30):48360-48374. doi: 10.18632/oncotarget.10235.

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.对治疗性程序性死亡蛋白1（PD-1）阻断的适应性耐药与其他免疫检查点的上调相关。

Nat Commun. 2016 Feb 17;7:10501. doi: 10.1038/ncomms10501.

A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.TIM-3/Gal-9 自分泌刺激环路驱动人类髓系白血病干细胞自我更新和白血病进展。

Cell Stem Cell. 2015 Sep 3;17(3):341-52. doi: 10.1016/j.stem.2015.07.011. Epub 2015 Aug 13.

Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands.带有 B7-2(+)亚群的髓性白血病细胞通过调节 B7 配体引发 T 细胞反应，并通过调节 B7 配体而具有免疫抑制作用。

Eur J Immunol. 2013 Mar;43(3):747-57. doi: 10.1002/eji.201242814. Epub 2013 Jan 31.

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.Tim-3 标志着人类自然杀伤细胞的成熟，并抑制细胞介导的细胞毒性。

Blood. 2012 Apr 19;119(16):3734-43. doi: 10.1182/blood-2011-11-392951. Epub 2012 Mar 1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验